DICE Therapeutics
opportunity for oral inhibitor target indication validation via clinical commercial success of a dice | DICE Therapeutics
Company
Deck Type
Deck date
March 2023
Slide
54 of 59
Related slides by other companies
Corecentric
Investor Presentation
May 2022
multiple vectors driving growth and upside | Corecentric
Corecentric
Investor Presentation
July 2022
multiple vectors driving growth and upside | Corecentric
Trian Partners
Activist
October 2018
believes focus is needed in the north architectural business has lost significant market share in north architectural coatings over the last few years one of its businesses in out of the last years has reported sales declines despite enjoying from growing us housing starts and construction spending and strong comparable sales in its paints stores | Trian Partners
Blackwells Capital
Activist
February 2022
a sale process will likely attract several strategic bidders | Blackwells Capital
Other recent decks by DICE Therapeutics
See all presentations (4 decks)
Results
March 2023
Investor Presentation
March 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io